Revision history of "Development of biotechnological tools for application in the prevention of leishmaniosis: from the use of DNA vaccines to leishmanisation with a geneticly attenuated strain." (Q3199802)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:5709:57, 11 October 2024DG Regio talk contribs 80,592 bytes +18 Changed label, description and/or aliases in pt
  • curprev 09:5709:57, 11 October 2024DG Regio talk contribs 80,574 bytes +19 Set a claim value: summary (P836): Ao longo dos últimos vinte anos, foram feitos grandes esforços para desenvolver vacinas contra a Leishmania baseadas em antigénios definidos. Algumas das proteínas imunogénicas caracterizadas foram testadas como produtos recombinantes em modelos experimentais de leishmaniose no ratinho. Além disso, estratégias de vacinação têm sido desenvolvidas utilizando parasitas geneticamente atenuados para induzir respostas efetoras de linfócitos T capazes de c...

23 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 09:3409:34, 18 August 2022DG Regio talk contribs 79,282 bytes +54,791 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 23:2723:27, 12 October 2021DG Regio talk contribs 12,963 bytes +233 Changed label, description and/or aliases in en: translated_label
  • curprev 23:2723:27, 12 October 2021DG Regio talk contribs 12,730 bytes +2,449 Created claim: summary (P836): Over the past twenty years, major efforts have been made to develop Leishmania vaccines based on defined antigens. Some of the characterised immunogenic proteins have been tested as recombinant products in experimental models of leishmaniosis in the mouse. In addition, vaccination strategies have been developed using genetically attenuated parasites to induce effector T lymphocyte responses capable of controlling infection at the inoculation sit...

11 October 2021

10 October 2021

8 October 2021